Response: GDF15 Is a Novel Biomarker for Impaired Fasting Glucose (Diabetes Metab J 2014;38:472-9)

Overview

Journal Diabetes Metab J

Specialty Endocrinology

Date 2015 Mar 3

PMID 25729718

Citations 2

Authors

Jun Hwa Hong

Bon Jeong Ku

Minho Shong

Affiliations

Soon will be listed here.

Citing Articles

Identification of biomarkers for glycaemic deterioration in type 2 diabetes.

Slieker R, Donnelly L, Akalestou E, Lopez-Noriega L, Melhem R, Gunes A Nat Commun. 2023; 14(1):2533.

PMID: 37137910 PMC: 10156700. DOI: 10.1038/s41467-023-38148-7.

The anti-diabetic effects of NAG-1/GDF15 on HFD/STZ-induced mice.

Lertpatipanpong P, Lee J, Kim I, Eling T, Oh S, Seong J Sci Rep. 2021; 11(1):15027.

PMID: 34294853 PMC: 8298384. DOI: 10.1038/s41598-021-94581-y.

References

Wasada T, Kuroki H, Katsumori K, Arii H, Sato A, Aoki K . Who are more insulin resistant, people with IFG or people with IGT?. Diabetologia. 2004; 47(4):758-9. DOI: 10.1007/s00125-004-1339-1. View

Hong J, Chung H, Park H, Joung K, Lee J, Jung J . GDF15 Is a Novel Biomarker for Impaired Fasting Glucose. Diabetes Metab J. 2014; 38(6):472-9. PMC: 4273034. DOI: 10.4093/dmj.2014.38.6.472. View

Warren B, Lou P, Lucchinetti E, Zhang L, Clanachan A, Affolter A . Early mitochondrial dysfunction in glycolytic muscle, but not oxidative muscle, of the fructose-fed insulin-resistant rat. Am J Physiol Endocrinol Metab. 2014; 306(6):E658-67. PMC: 3948982. DOI: 10.1152/ajpendo.00511.2013. View

Kempf T, Guba-Quint A, Torgerson J, Magnone M, Haefliger C, Bobadilla M . Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial. Eur J Endocrinol. 2012; 167(5):671-8. DOI: 10.1530/EJE-12-0466. View

Strelau J, Bottner M, Lingor P, Suter-Crazzolara C, Galter D, Jaszai J . GDF-15/MIC-1 a novel member of the TGF-beta superfamily. J Neural Transm Suppl. 2001; (60):273-6. DOI: 10.1007/978-3-7091-6301-6_18. View

Fujita Y, Ito M, Kojima T, Yatsuga S, Koga Y, Tanaka M . GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases. Mitochondrion. 2014; 20:34-42. DOI: 10.1016/j.mito.2014.10.006. View

Hur K . Is GDF15 a Novel Biomarker to Predict the Development of Prediabetes or Diabetes?. Diabetes Metab J. 2014; 38(6):437-8. PMC: 4273029. DOI: 10.4093/dmj.2014.38.6.437. View

Kalko S, Paco S, Jou C, Rodriguez M, Meznaric M, Rogac M . Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies. BMC Genomics. 2014; 15:91. PMC: 3937154. DOI: 10.1186/1471-2164-15-91. View

Dostalova I, Roubicek T, Bartlova M, Mraz M, Lacinova Z, Haluzikova D . Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. Eur J Endocrinol. 2009; 161(3):397-404. DOI: 10.1530/EJE-09-0417. View

10.

Lowell B, Shulman G . Mitochondrial dysfunction and type 2 diabetes. Science. 2005; 307(5708):384-7. DOI: 10.1126/science.1104343. View